---
title: "Questions linger: BASIL-3 does not find for drug-eluting technologies for CLTI"
date: "2024-04-23T22:55:46.000Z"
publishedDate: "23 avril 2024"
summary: "In the UK National Institute for Health and Care Research (NIHR) Health Technology Assessment (HTA)-funded BASIL-3 randomised controlled trial (RCT), neither drug-coated balloon (DCB) angioplasty with or without bare metal stent nor drug-eluting stent (DES), when used in the femoropopliteal segment, conferred a hypothesised clinical benefit over femoropopliteal plain balloon angioplasty with or without bare [&#8230;] The post Questions linger: BASIL-3 does not find for drug-eluting technologies for CLTI appeared first on Vascular News ."
importance: ""
sourceUrl: "https://vascularnews.com/questions-linger-basil-3-does-not-find-for-drug-eluting-technologies-for-clti/"
tags: ["France", "Actualité", "Vascular News — Latest"]
permalink: "/papers/2024-04-23-questions-linger-basil-3-does-not-find-for-drug-eluting-technologies-for-clti"
imageUrl: "https://vascularnews.com/wp-content/uploads/sites/7/2024/04/BASIL-3-featured-pic.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://vascularnews.com/questions-linger-basil-3-does-not-find-for-drug-eluting-technologies-for-clti/"
---

![Questions linger: BASIL-3 does not find for drug-eluting technologies for CLTI](https://vascularnews.com/wp-content/uploads/sites/7/2024/04/BASIL-3-featured-pic.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://vascularnews.com/questions-linger-basil-3-does-not-find-for-drug-eluting-technologies-for-clti/*

## L’essentiel

In the UK National Institute for Health and Care Research (NIHR) Health Technology Assessment (HTA)-funded BASIL-3 randomised controlled trial (RCT), neither drug-coated balloon (DCB) angioplasty with or without bare metal stent nor drug-eluting stent (DES), when used in the femoropopliteal segment, conferred a hypothesised clinical benefit over femoropopliteal plain balloon angioplasty with or without bare [&#8230;] The post Questions linger: BASIL-3 does not find for drug-eluting technologies for CLTI appeared first on Vascular News .

## Lien source

https://vascularnews.com/questions-linger-basil-3-does-not-find-for-drug-eluting-technologies-for-clti/
